First patients at multiple sites are expected to be enrolled in the NEPHRO CRRT registrational study in Q2 2024 Dr. Shakil Aslam, an expert in renal diseases, including acute kidney injury, joins Talphera as Chief Development Officer Cash and investments at March 31, 2024 of $18.6 million Conference call and webcast to be held Tuesday,… Continue reading Talphera Announces First Quarter 2024 Financial Results and Provides Corporate Update
Category: Newswire
Kyverna Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
Advanced clinical development in two broad areas of autoimmune disease: rheumatology and neurology Treated 30 patients cumulatively as of May 14, 2024, including eight patients with myasthenia gravis, seven patients with lupus nephritis, and four patients with multiple sclerosis Strong balance sheet, bolstered by recent public offering EMERYVILLE, Calif., May 14, 2024 /PRNewswire/ — Kyverna… Continue reading Kyverna Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
Agree Realty Declares Monthly Common and Preferred Dividends
ROYAL OAK, Mich., May 14, 2024 /PRNewswire/ — Agree Realty Corporation (NYSE: ADC) (the “Company”) today announced that its Board of Directors has authorized, and the Company has declared, a monthly cash dividend of $0.250 per common share. The monthly dividend reflects an annualized dividend amount of $3.00 per common share, representing a 2.9% increase… Continue reading Agree Realty Declares Monthly Common and Preferred Dividends
Poseida Therapeutics Provides Updates and Financial Results for the First Quarter of 2024
Expanded strategic relationship with Astellas with new research collaboration leveraging Poseida’s proprietary allogeneic CAR-T platform to develop cell therapies targeting solid tumors Generated $95 million in milestone and upfront payments to-date in 2024, including $50 million from Astellas collaboration and $45 million from continued execution in the Company’s CAR-T partnership with Roche Presented promising early… Continue reading Poseida Therapeutics Provides Updates and Financial Results for the First Quarter of 2024
Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2024 Financial Results and Provides Business Update
Mino-Lok data analysis on track with topline results anticipated this quarter LYMPHIR biologics license application accepted with PDUFA target action date set for August 13, 2024 CRANFORD, N.J., May 14, 2024 /PRNewswire/ — Citius Pharmaceuticals, Inc. (“Citius” or the “Company”) (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care… Continue reading Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2024 Financial Results and Provides Business Update
Pixelworks Reports First Quarter 2024 Financial Results
Total Revenue Increased 61% Year-over-Year; Mobile Revenue Grew nearly 200% Year-over-Year, Reaching a Record 61% of Total Revenue PORTLAND, Ore., May 14, 2024 /PRNewswire/ — Pixelworks, Inc. (NASDAQ: PXLW), a leading provider of innovative video and display processing solutions, today announced financial results for the first quarter ended March 31, 2024. First Quarter and Recent… Continue reading Pixelworks Reports First Quarter 2024 Financial Results
Precigen Reports First Quarter 2024 Financial Results and Business Updates
– Pivotal Phase 2 study data of PRGN-2012 for the treatment of patients with recurrent respiratory papillomatosis to be presented at the 2024 ASCO Annual Meeting as a late-breaking oral presentation on June 3rd – – Company to host a conference call on June 3rd following the PRGN-2012 ASCO presentation to discuss in detail the… Continue reading Precigen Reports First Quarter 2024 Financial Results and Business Updates
The Shipyard Completes Acquisition of Fahlgren Mortine, National Public Relations Agency of the Year
Merged company gains critical scale to disrupt industry and “Engineer Brand Love” COLUMBUS, Ohio, May 14, 2024 /PRNewswire/ — The Shipyard, one of Adweek’s Fastest Growing Agencies nationally, has acquired Fahlgren Mortine – one of the top 20 firms in the nation (O’Dwyer’s), and the two-time reigning Mid-Sized Agency of the Year as designated by… Continue reading The Shipyard Completes Acquisition of Fahlgren Mortine, National Public Relations Agency of the Year
VOXX International Corporation Reports its Fiscal 2024 Fourth Quarter and Year-end Financial Results
ORLANDO, Fla., May 14, 2024 /PRNewswire/ — VOXX International Corporation (NASDAQ: VOXX), a leading manufacturer and distributor of automotive and consumer technologies for the global markets, today announced its financial results for its Fiscal 2024 fourth quarter and year-ended February 29, 2024. Commenting on the Company’s results and market outlook, Pat Lavelle, Chief Executive Officer stated,… Continue reading VOXX International Corporation Reports its Fiscal 2024 Fourth Quarter and Year-end Financial Results
ROSEN, A TOP RANKED LAW FIRM, Encourages Xiao-I Corporation Investors to Inquire About Securities Class Action Investigation – AIXI
NEW YORK, May 14, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Xiao-I Corporation (NASDAQ: AIXI) resulting from allegations that Xiao-I Corporation may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Xiao-I… Continue reading ROSEN, A TOP RANKED LAW FIRM, Encourages Xiao-I Corporation Investors to Inquire About Securities Class Action Investigation – AIXI